ESC Heart Failure (Aug 2020)

Echocardiographic analysis of acute effects of percutaneous mitral annuloplasty on severity of secondary mitral regurgitation

  • Stephan Stöbe,
  • Kristin Kreyer,
  • Daniel Jurisch,
  • Dietrich Pfeiffer,
  • Daniel Lavall,
  • Gerardo Farese,
  • Ulrich Laufs,
  • Andreas Hagendorff

DOI
https://doi.org/10.1002/ehf2.12719
Journal volume & issue
Vol. 7, no. 4
pp. 1645 – 1652

Abstract

Read online

Abstract Aims Percutaneous mitral annuloplasty (PMA) represents a new treatment option for secondary mitral regurgitation (SMR) being associated with higher morbidity and mortality. The present study was aimed to evaluate whether or not acute effects on SMR severity can quantitatively be assessed after PMA. Methods and results PMA was performed in 30 patients (mean age 76 ± 9; 37% males) with moderate (n = 14) or severe (n = 16) SMR. Vena contracta (VC), left ventricular (LV) velocity‐time‐integral ratio (VTIMV/LVOT), effective regurgitant orifice area (EROA) by two‐dimensional proximal isovelocity surface area (PISA), regurgitant volume (RVolPISA) and regurgitant fraction (RFPISA) by PISA, RVolvolume and RFvolume by LV volume analyses, and parameters describing LV morphology, function, and cardiac performance were assessed by transthoracic echocardiography prior to and after PMA. According to RFPISA/RFvolume, 14 patients showed mild, 15 moderate, and 1 severe SMR after PMA. Mean RF, RVol, EROA, VC, and VTIMV/LVOT were lower directly after PMA (RFPISA: 49% ± 11 vs. 34% ± 13, P 80% of SMR patients. Acute effects of PMA can quantitatively be assessed by transthoracic echocardiography.

Keywords